Table 4 The nine principal components in scaled phenotypic space.
From: A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes
Principal Component | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
|---|---|---|---|---|---|---|---|---|---|
Ritonavir | 0.39 | 0.35 | 0.60 | -0.16 | 0.30 | -0.37 | -0.32 | -0.05 | -0.07 |
Nelfinavir | 0.36 | 0.33 | 0.22 | -0.05 | -0.10 | 0.31 | 0.75 | -0.11 | 0.17 |
Atazanavir | 0.39 | 0.12 | -0.10 | 0.23 | 0.01 | 0.72 | -0.49 | -0.12 | -0.04 |
Amprenavir | 0.36 | -0.29 | -0.17 | -0.49 | 0.29 | 0.13 | 0.07 | 0.63 | -0.12 |
Indinavir | 0.33 | 0.04 | -0.14 | -0.02 | -0.62 | -0.23 | 0.02 | -0.02 | -0.65 |
Lopinavir | 0.31 | -0.12 | -0.18 | -0.33 | -0.43 | -0.19 | -0.21 | -0.15 | 0.67 |
Saquinavir | 0.38 | 0.15 | -0.48 | 0.58 | 0.29 | -0.38 | 0.11 | 0.14 | 0.14 |
Tipranavir | 0.23 | -0.71 | 0.48 | 0.43 | -0.12 | -0.02 | 0.07 | 0.07 | 0.07 |
Darunavir | 0.19 | -0.37 | -0.21 | -0.23 | 0.39 | -0.04 | 0.12 | -0.72 | -0.21 |
Percent Variance (%) | 83.7 | 6.0 | 3.1 | 2.7 | 1.6 | 1.0 | 1.0 | 0.6 | 0.3 |